LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 2 | G11 | 72 | hr | 1476 | 4128 | 3694 | 1.1175 | 1.1957 |
SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 3 | G11 | 72 | hr | 1476 | 4347 | 3694 | 1.1768 | 1.2945 |
SK-BR-3 | Saracatinib | 0.12 | uM | LJP6 | 1 | D11 | 72 | hr | 1476 | 4261 | 3694 | 1.1535 | 1.2557 |
SK-BR-3 | Saracatinib | 0.12 | uM | LJP6 | 2 | D11 | 72 | hr | 1476 | 3888 | 3694 | 1.0525 | 1.0875 |
SK-BR-3 | Saracatinib | 0.12 | uM | LJP6 | 3 | D11 | 72 | hr | 1476 | 4326 | 3694 | 1.1711 | 1.2850 |
SK-BR-3 | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 1476 | 3727 | 3694 | 1.0089 | 1.0149 |
SK-BR-3 | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 1476 | 3649 | 3694 | 0.9878 | 0.9797 |
SK-BR-3 | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 1476 | 3765 | 3694 | 1.0192 | 1.0320 |
SK-BR-3 | Sirolimus | 0.12 | uM | LJP6 | 1 | L17 | 72 | hr | 1476 | 1848 | 3694 | 0.5003 | 0.1675 |
SK-BR-3 | Sirolimus | 0.12 | uM | LJP6 | 2 | L17 | 72 | hr | 1476 | 2824 | 3694 | 0.7645 | 0.6076 |
SK-BR-3 | Sirolimus | 0.12 | uM | LJP6 | 3 | L17 | 72 | hr | 1476 | 2488 | 3694 | 0.6735 | 0.4561 |
SK-BR-3 | Sorafenib | 0.12 | uM | LJP6 | 1 | B11 | 72 | hr | 1476 | 3297 | 3694 | 0.8925 | 0.8209 |
SK-BR-3 | Sorafenib | 0.12 | uM | LJP6 | 2 | B11 | 72 | hr | 1476 | 3293 | 3694 | 0.8914 | 0.8191 |
SK-BR-3 | Sorafenib | 0.12 | uM | LJP6 | 3 | B11 | 72 | hr | 1476 | 3292 | 3694 | 0.8912 | 0.8187 |
SK-BR-3 | SU11274 | 0.12 | uM | LJP5 | 1 | J11 | 72 | hr | 1476 | 4171 | 3694 | 1.1291 | 1.2151 |
SK-BR-3 | SU11274 | 0.12 | uM | LJP5 | 2 | J11 | 72 | hr | 1476 | 4297 | 3694 | 1.1632 | 1.2719 |
SK-BR-3 | SU11274 | 0.12 | uM | LJP5 | 3 | J11 | 72 | hr | 1476 | 4144 | 3694 | 1.1218 | 1.2029 |
SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 1 | L05 | 72 | hr | 1476 | 3661 | 3694 | 0.9911 | 0.9851 |
SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 2 | L05 | 72 | hr | 1476 | 3873 | 3694 | 1.0484 | 1.0807 |
SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 3 | L05 | 72 | hr | 1476 | 3875 | 3694 | 1.0490 | 1.0816 |
SK-BR-3 | TGX221 | 0.12 | uM | LJP5 | 1 | H23 | 72 | hr | 1476 | 3335 | 3694 | 0.9028 | 0.8381 |
SK-BR-3 | TGX221 | 0.12 | uM | LJP5 | 2 | H23 | 72 | hr | 1476 | 3061 | 3694 | 0.8286 | 0.7145 |
SK-BR-3 | TGX221 | 0.12 | uM | LJP5 | 3 | H23 | 72 | hr | 1476 | 3007 | 3694 | 0.8142 | 0.6904 |
SK-BR-3 | Torin1 | 0.12 | uM | LJP6 | 1 | O17 | 72 | hr | 1476 | 1614 | 3694 | 0.4369 | 0.0619 |
SK-BR-3 | Torin1 | 0.12 | uM | LJP6 | 2 | O17 | 72 | hr | 1476 | 1578 | 3694 | 0.4272 | 0.0457 |